Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Quanta Humidifier™ New Technology Turns Ultrasonic Humidifiers Into Nucleophile Generators with Hydroxyl Air Humidification for Air and Surface Sterilization


quanta-humidifier-oh-

quanta-humidifier-oh-

The most technologically sophisticated and advanced consumer designed and priced water to air and surface treatment device in the world!

The Quanta Humidifier™ is the world’s first ever hydroxyl air humidification and sterilization system without UV or toxic ozone which was previously a by-product of hydroxyl production before the introduction of the Quanta Humidifier™ for disinfecting occupied spaces with UV free supercharged OH- Hydroxyl ions.

What it boils down to is human safe negative ion enriched humidification.

The New Quanta Humidifier™ Antimicrobial Air Humidification and Sterilization System simply replicates nature’s ability to generate the hydroxyl molecules that are found in the earth’s atmosphere, allowing the innovative new Quanta Humidifier™ to create them indoors for a healthy indoor environment.

The Quanta Humidifier™ Antimicrobial Air Humidification, Air Purification and Air Sterilization Humidifier product is the most technologically sophisticated and advanced consumer designed and priced water to air and surface treatment device in the world, just released as of 8/15/2020!

It is the world’s only air humidifier sterilizer that has a non-UV Hydroxyl Generator for inhabited areas that has ever been made!

Media reporters from around the world can reach our engineer team 24 hrs a day through September 1st at 727 300-1612 or in the USA 1 -800 -713 -9004

The Company’s CEO is currently ramping up production to meet forecast in demand, “Currently we are manufacturing 10,000 Quanta Humidifiers a month, and we are already working on scaling production to meet the needs of this amazing innovation contained inside a small reactor that does big things to protect people!”, said Webb

The Quanta Humidifier™ took designed considerations for a easy to use air disinfection process that uses low voltage, only 24 volts, so this device can be powered globally in areas with limited electricity around the world.

According to Quanta X Technology CEO, Katie Webb “The Quanta Humidifier™ releases an army of nucleophiles that can target a virus while providing a perfect level of humidity in occupied areas using completely safe air-born ultrasonic hydroxyl ions carried in droplets of disassociated water.”

“It is a huge break-through to cheaply protect people most at risk. This is the perfect solution for occupied spaces such as homes, waiting rooms, doctor offices, and nursing homes – anywhere people temporarily gather”, says Webb.

The Quanta Humidifier is a huge breakthrough technology for indoor humidification air quality control devices to aid in pandemic countermeasures with a life span of 2000 hours.

Quanta Humidifier™ proves Humidifier’s can do more than just add water into the air. This innovation, creates a new class of antimicrobial air humidifiers with an all natural air-cleansing agent that creates an oxygenated hydroxyl mist, with the power of hydroxyl ions, to purify air of bad smells and bad germs with the diatomic anion chemical formula of OH− within the chemistry of water.

OH− consists of an oxygen and hydrogen atom held together by a covalent bond, and carries a negative electric charge. It is an important constituent of electrolyzed water.

H2O exposed to electrolysis causes a catalytic process that creates powerful antimicrobial hydroxyls, or hydroxyl ions (OH).

Inside the Quanta Humidifier water (H2O) molecules are instantaneously converted into hydroxyl ions and launched into the air to fill a room up to 1000 sq feet with a powerful disinfecting agent safe for people filling the air.

These highly reactive hydroxyl ions are negatively charged hydroxyls in water that can easily cause damage to a positively charged viral protein coat or cell membrane because it is not repelled, as a proton is ripped from the virus — the by-product results in water vapor (H2O) being formed by the Hydrogen Ion.

Get your nucleophiles right here in the USA to keep the party of life going strong!

Learn more at QuantaDose.com

Share article on social media or email:

Widener University Delaware Law School and First Healthcare Compliance Announce Speakers for Virtual HIPAA Privacy and Security Summit on November 12, 2020


Virtual HIPAA Privacy and Security Summit on November 12, 2020

Attendees are eligible to receive CLE in Delaware, Pennsylvania, and New Jersey. CEU credits will be available through the Professional Association of Healthcare Office Managers (PAHCOM) and the Practice Management Institute (PMI).

The HIPAA Privacy and Security Summit will bring professionals from the healthcare and legal communities together for online discussion and learning. Thought leaders will provide meaningful insight on topics related to the HIPAA privacy and security rules with updates to address the impact of the COVID public health crisis.

An annual event, the HIPAA Privacy and Security Summit is a joint effort to conveniently provide resources for professionals facing the challenges of complying with often misunderstood rules. Attendees are eligible to receive CLE in Delaware, Pennsylvania, and New Jersey. CEU credits will be available through the Professional Association of Healthcare Office Managers (PAHCOM) and the Practice Management Institute (PMI). The virtual learning event will be held from 12:00 pm ET until 5:00 pm ET and will include discussion sessions along with sponsor giveaways and prizes. Registration is open to the public.

The event speakers and presentations include:

Kathleen McNicholas, MD, JD, CHC, CCEP

Ethics and 20 years of HIPAA

Iliana Peters, Esq.

What’s Your Nightmare? Cyber-attacks During the COVID Public Health Emergency

Rebecca Rakoski, Esq.

Updates on Data Privacy Regulations

Rachel V. Rose, JD, MBA

HIPAA Hot Topics

John Shegerian, Executive Chairman of ERI

Hardware Data Hacking and HIPAA: the Overlooked Cybercrime

Delaware Law School offers online health care compliance degrees through its Graduate, International, Compliance and Legal Studies department. Master degree programs and graduate certificates are available for both lawyers and non-lawyers. Completion of the program allows successful students with eligibility to sit for the Compliance Certification Board examination to become a CHC (Certified in Healthcare Compliance) professional. Delaware’s graduate programs are offered entirely online in an interactive format led by professional compliance-expert faculty, featuring rigorous practical skills training, and the tools needed to prepare for the certification exam and an exciting career in healthcare compliance. Students can complete the certificate in just nine months, or the master’s degree in one year (full time) or two years (part time). The health law and compliance degrees at Delaware Law School have been ranked #4 in the nation for best online health policy master’s degrees. To learn more about the program options, visit delawarelaw.widener.edu/compliance or email delawarelawgicls@widener.edu.

About First Healthcare Compliance: Founded in 2012 by a nurse attorney, the First Healthcare Compliance software solution creates confidence among compliance professionals through education, resources, and support in the areas of HIPAA, OSHA, human resources compliance, and fraud waste and abuse laws. Serving clients across the United States, the company’s evolving platform provides real-time insight for board reporting and across multiple locations. For more information please visit https://1sthcc.com/

Share article on social media or email:

Lung Injuries from Vaping Have Characteristic Patterns on CT


Electronic cigarette or vaping product use–associated lung injury in a 51-year-old man manifesting as an acute lung injury pattern at CT with subsequent organization.

We hope to make radiologists aware that if they see diffuse lung opacities in a younger patient without clearly defined causes, then they may want to seriously consider that the patient could have a vaping injury.

Injuries to the lungs from vaping have suggestive patterns on CT scans that could help physicians make accurate diagnoses and reduce unnecessary biopsies, according to a new study published in the journal Radiology: Cardiothoracic Imaging.

Electronic nicotine delivery systems such as e-cigarettes and vaporizers heat nicotine, flavorings and other chemicals to create an aerosol that the user inhales. Use of these devices has grown rapidly over the past decade, particularly among young people. The inhaled aerosols, commonly referred to as “juices,” may contain a number of potentially toxic or damaging substances.

Last year, the Centers for Disease Control and Prevention (CDC) received its first report on an illness known as electronic cigarette or vaping product use-associated lung injury (EVALI). Three criteria define EVALI: e-cigarette use or vaping within 90 days from symptom onset, abnormalities on chest imaging and the exclusion of other potential sources of injury like infection. Almost 3,000 hospitalized EVALI cases were reported to CDC within six months of the first case, with 68 deaths confirmed.

Also last year, pathologists at Mayo Clinic in Scottsdale, Arizona, published a paper describing a peculiar pattern of lung injury in young people using vape products. The injuries were wrapped around the bronchi, the tubes that branch off the trachea into the lungs.

Mayo Clinic radiologist Michael B. Gotway, M.D., recently expanded on that study by looking for patterns on chest CT scans that might correlate with the previously observed pathological findings. The study included 26 patients who met the EVALI criteria and had undergone CT and biopsy or some other type of tissue removal. Dr. Gotway and colleagues classified the CT scan pattern according to several different recognized patterns. One pattern is ground glass opacity, an area on the CT scan that appears whiter than normal but does not obscure the underlying structure of the lung. Another is consolidation, or denser white areas on CT.

“We read the CT scan and then plugged it into one of those patterns and correlated that with histopathology,” Dr. Gotway said. “What we found out was that ground glass opacity, sometimes with consolidation, is by far the most common pattern that we see with EVALI.”

That pattern was found more commonly than a CT pattern resembling subacute hypersensitivity pneumonitis, a term for the inflammation of lung tissue.

The findings of this study and other related research could provide an important diagnostic tool for physicians treating young patients who express symptoms like chest pain and shortness of breath.

“We hope to make radiologists aware that if they see diffuse lung opacities in a younger patient without clearly defined causes, then they may want to seriously consider that the patient could have a vaping injury,” Dr. Gotway said. “Patients may not readily admit that they’re using the material, but if a radiologist recognizes these patterns and then tells the clinician that it could be vaping-induced injury, then maybe they could test for a nicotine metabolite or ask the patient about this exposure.”

Such an approach could help reduce lung biopsies, which carry considerable expense, some risk of complications and additional anxiety for the patient.

“These radiological findings will be especially beneficial to physicians to help them determine potentially less invasive treatment options,” Dr. Gotway said. “We could potentially make that diagnosis noninvasively through cooperation with our clinical colleagues. By alerting them to a scan pattern that is suggestive of the possibility of EVALI, we may actually save patients from having to meet a surgeon.”

The researchers found some good news in their study, as it appears that signs of EVALI on imaging may resolve quickly with cessation of use of the offending agent, often supplemented by corticosteroid therapy.

###

“Pulmonary Injury Resulting from Vaping or e-Cigarette Use: Imaging Appearances at Presentation and Follow-up.” Collaborating with Dr. Gotway were Prasad M. Panse, M.D., Fionna F. Feller, M.D., Yasmeen M. Butt, M.D., Maxwell L. Smith, M.D., Brandon T. Larsen, M.D., Ph.D., Henry D. Tazelaar, M.D., and Howard J. Harvin, M.D.

Radiology: Cardiothoracic Imaging is edited by Suhny Abbara, M.D., University of Texas Southwestern Medical Center, Dallas, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/cardiothoracic-imaging)

RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)

For patient-friendly information on lung CT, visit RadiologyInfo.org.

Share article on social media or email:

Haute Beauty Welcomes Renowned Body Expert Dr. Karan Chopra To The Haute Beauty Network


News Image

“Dr. Karan Chopra has an ongoing commitment to excellence in cosmetic surgery of the face, eyes, breast and body.”

Dr. Karan Chopra obtained his doctor of medicine (MD) degree at the University of Maryland School of Medicine. Dr. Chopra was then accepted into the premier Johns Hopkins & University of Maryland Integrated Residency Program in Plastic and Reconstructive Surgery where he trained and served as Chief Resident under leaders in the field of Plastic, Reconstructive, Aesthetic, and Craniofacial Surgery. He went on to complete an Oculoplastic & Aesthetic Plastic Surgery Fellowship with Mark Codner in Atlanta where he focused on cosmetic surgery procedures of the eyes, face, breast, and body.

Dr. Chopra is known for his genuine kindness, affability, and his individualized care and attention to each patients’ needs. He has an ongoing commitment to excellence in cosmetic surgery of the face, eyes, breast and body. These procedures include facelift, eyelid lifts, breast surgery and, tummy-tuck, fat grafting, Jeuveau, Botox, dermal fillers and more.

Visit Dr. Karan Chopra’s Haute Beauty profile at: https://hauteliving.com/hautebeauty/member/dr-karan-chopra/

Visit Dr. Karan Chopra’s website at: https://www.tcplasticsurgery.com/

ABOUT HAUTE BEAUTY:

Haute Beauty offers readers access to an invite-only, prominent collective of leading doctors and industry-leading aesthetic surgeons located in their area. Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed surgeons.

To learn more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

GeniusVets to Host “Defeating the Phone Frenzy” Webinar to Help Practices Improve Communication During COVID


Even beyond that initial communication, veterinarians need to consider training, strategies, and even ethics—including the slippery slope of receptionists inadvertently practicing medicine over the phone.

Veterinarians have had to make major shifts to accommodate the needs of their patients during this pandemic while keeping their staff and clients safe. Of course, practice owners are very familiar with the need for curbside service; one unanticipated effect of this shift is that according to GeniusVets survey data, call volumes have increased by 104% (more than doubled) at practices across the country. This requires new strategies, tools, and approaches to ensure continued excellent client service.

As a DVM and the owner of The Drake Center in Encinitas, California, Dr. Michele Drake knew that a huge change was needed to speed up call response times and ensure her high standards of client service were maintained despite the challenges of COVID.

“To support my clients during this difficult time, I’ve leaned on the training and culture-building strategies I’ve had in place at The Drake Center for many years, but I’ve increased our internal communication and support. I also worked with my partner and GeniusVets CEO, Harley Orion, to find technology tools to get the inbound phone calls under control,” Dr. Drake noted. “My team was able to find technology solutions that allowed for managing client arrivals at curbside by text—streamlining communication and, in turn, greatly increasing efficiency.”

Orion echoed Dr. Drake’s sentiments but further noted, “Even beyond that initial communication, veterinarians need to consider training, strategies, and even ethics—including the slippery slope of receptionists inadvertently practicing medicine over the phone. If you’re not utilizing call tracking, monitoring hold times, and leveraging online profiles to acquire appointments through digital channels, you risk losing your clients to the competition.”

The advice given during the webinar will include how to handle high call volume, manage call times, define your veterinary practice’s phone processes, and make the most of text messaging; as well as how to effectively track, monitor, and review calls to ensure great client service.

GeniusVets—the top-performing marketing agency serving the veterinary industry—is hosting this “Defeating the Phone Frenzy” event as part of their Webinar Wednesday series on September 2 from 4-5 PST.

Special guests from Zingle, a leading text-based client service platform, will be joining to share how The Drake Center and other practices have leveraged their tools to deliver text-based arrival management for curbside, improving patient flow and efficiency.

Reservations are required and space is limited. To register for this webinar, visit https://www.geniusvets.com/webinar.

About GeniusVets

GeniusVets is the premier platform that connects pet parents with quality veterinarians and proven pet care advice from DVMs. The mission of GeniusVets is to create better pet health by educating and uniting pet owners and veterinarians. For more information about GeniusVets, visit geniusvets.com.

Contact

Harley Orion

media@geniusvets.com

Share article on social media or email:

NeoTract Designates Dr. Ali Kasraeian as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Ali Kasraeian as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Ali Kasraeian, M.D., Kasraeian Urology in Jacksonville, FL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Kasraeian has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Ali Kasraeian as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

MT2 Firing Range Services Celebrates 20 Years of Providing Environmental Gun Range Services, Lead Reclamation and Remediation.


Gun Range Cleaning Services Lead Maintenance Contractor

Our company is celebrating 20 years, but we also feel like we’re just getting started on the important work of empowering firing range managers and owners to properly manage their range lead with exclusive patented technologies that no other gun range services contractor can perform

“At MT2, we are deeply proud of the progress we’ve made to help gun ranges protect their shooters, employees and community from the dangers of lead,” said MT2 President James M. Barthel. “Our company is celebrating 20 years, but we also feel like we’re just getting started on the important work of empowering firing range managers and owners to properly manage their range lead with exclusive patented technologies that no other gun range services contractor can perform,” Barthel continued.

Barthel founded the company in 2000, after 15 years in the environmental engineering business working for the U.S. Department of Energy. They focus first on service/product excellence and identify a higher purpose to fulfill in serving their clients and strategic alliances. Clients and employees are motivated and drawn toward a strong commitment to excellence and selfless attitude. The team gets a lot of satisfaction from serving over 3,000 ranges nationwide for Law Enforcement, Military and Commercial ranges in all 50 states.

MT2 is an A+ BBB accredited business with a multi-year certification from Great Places to Work and is the Firing Range Lead Management Authority. They are OSHA/EPA experts with no violations and take no shortcuts. As the nation’s #1 range support firm, MT2 specializes in safety and environmental assessment, consulting services, lead reclamation, range and bullet trap installations, maintenance cleaning, renovations and improvements, lead-waste management,

construction and construction management of new ranges.

About MT2 Firing Range Services:

MT2 specializes in providing environmental firing range services, and lead remediation for all your indoor and outdoor gun range services needs including:

  • Lead cleaning services,
  • Lead reclamation & Brass recycle
  • Range Maintenance, HVAC systems support
  • Consulting and Assessment by our OSHA/EPA experts!
  • Range Construction and Renovation
  • Lead Remediation & Abatement


We operate from regional offices across the country and always pay the highest value for range lead guaranteed!

Learn more: https://www.MT2FiringRangeServices.com

Share article on social media or email:

Analysis of the Latest Developments Webinar Aug. 13, 2020


WCG CenterWatch

WCG CenterWatch

Expanded Access:

Analysis of the Latest Developments

An FDAnews/CenterWatch Webinar

Thursday, Sept. 10, 2020, 1:30-3:00 p.m. EDT

https://www.fdanews.com/expandedaccess

Between COVID-19 and the FDA’s announcement of Project Facilitate, expanded access is getting more momentum.

This webinar will explore the expanded access terrain, provide an update on current regulatory changes and address possible policy solutions to this treatment dilemma. Lisa Dwyer, Preeya Noronha Pinto and David Farber are partners with significant expanded access expertise in the FDA/Life Sciences practice at King & Spalding, based in Washington, DC. They will explain:

  • The existing legal and regulatory landscape driving expanded access, including 21 U.S.C. 360bbb-0 (Section 561b of the Food, Drug and Cosmetic Act)            
  • Recent congressional changes and how the FDA is implementing those changes, such as the recent FDA Proposed Rule on Annual Summary Reporting Requirements under the Right to Try Act, found at 85 Fed. Reg. 44803 (July 24, 2020)
  • The FDA’s voluntary efforts to increase use of expanded access, including the new Project Facilitate
  • Arguments in favor of and opposed to Right to Try, including whether it will help or harm patient access, if anyone is using the pathway, and whether mainstream manufacturers would ever want to use the pathway.
  • Policy considerations underlying the expanded access debate, such as monitoring and tracking of expanded access outcomes and adverse events.
  • The use of expanded access data as real-world evidence, including the use of expanded access outcomes results in the NDA review process or for coverage and reimbursement purposes.

Expanded access is evolving. Successfully navigate the new landscape.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Expanded Access:

Analysis of the Latest Developments

A CenterWatch/FDAnews Webinar

Thursday, Sept. 10, 2020, 1:30-3:00 p.m. EDT

https://www.fdanews.com/expandedaccess

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/expandedaccess

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

About CenterWatch:

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Share article on social media or email:

Tom Leonard Named Director, PEO & Special Risk at Benefits Science Technologies


Benefits Science Technologies (BST) announced today that Tom Leonard has been named Director of PEO & Special Risk. He brings the requisite expertise and profile to effectively manage BST’s division providing solutions to PEO, stop-loss writers, and other risk-bearing entities that would benefit from BST’s unique blend of data warehousing and data optimization tools.

Tom will apply his experience in analytics and machine learning models to identify key cost drivers, improve risk margins, and recommend predictive risk and underwriting methodology changes to help clients optimize their complex healthcare decisions.

“Tom brings over 25 years of experience in a wide variety of leadership roles and actuarial positions within the healthcare market to our team,” said Stephen Sofoul, MBA, CEO & President. “His unique insights into this specialized market will play an important role as we continue to execute our strategic priority to lead innovation in the healthcare decision space – to help clients better define, predict, and prescriptively respond to risk.”

Tom brings over 25 years of experience in a wide variety of leadership roles and actuarial positions within the healthcare market, including lead financial officer and actuary of a number of business units with Great-West Specialty Risk, Milliman Brazil and as Aon’s lead PEO healthcare actuary.

“I am excited to join BST’s amazing team of data scientists, actuaries, and IT professionals who have created groundbreaking data science and optimization techniques,” said Leonard, “PEOs and ESL writers can now apply models that are faster and more insightful to focus on the key issues rather than spend weeks and months trying to process data.”

Tom served as Senior Managing Director of Aon’s Reinsurance Solutions Division, where he developed and delivered analytical solutions to accident-health-life companies purchasing healthcare reinsurance. Prior to that he was the Senior Vice president and West Region Actuarial Practice Lead at Aon Healthcare. In this role, he led 30 actuaries in delivering actuarial results to a variety of as Fortune 500 firms, Welfare Trusts, Professional Employment Organizations (PEOs), and state health plans ranging in size from $100M in medical spend up to well in excess of $1.5B

He received his B.S. in Interdisciplinary Mathematics and Statistics with an Actuarial Science Option, graduating with distinction from Purdue University, Indiana. He is a Fellow with the Society of Actuaries and member of the American Academy of Actuaries. Tom and his family currently reside in Denver, Colorado.

About Benefits Science Technologies

BST provides data analytics software/analysis to help manage the risk of self-funded health plans. Plan holders improve their connection to data, empowering optimal decisions to control costs, and improve the quality of care for plan members. The company distributes these capabilities to employers directly, through brokers/consultants, or by association with carriers (stop-loss and voluntary benefits providers), benefit administrators, PEOs, TPAs, PBMs, and/or cost-containment providers.

Founded in 2012, the company is recognized as a world-leading research and applied science team, applying advanced analytics and Robust Optimization to complex health insurance decisions. Led by a 30-year MIT professor and Co-Director of the Operations Research Center, the MIT-trained team combines world-class technical knowledge and practical financial experience.

A powerful and unique feature of the platform lies in its ability to provide prescriptive recommendations. The company’s Health Plan Optimizer designs optimal health plan configurations while obeying overall premium, business quality, and other plan owner-specified criteria. These tools enable consultants/brokers and employers to model “what if” scenarios for plan configuration, including stop-loss and supplemental plan design. BST delivers timely, customized business intelligence, tailored to the specific healthcare needs of the group, empowering decision-makers to maximize every healthcare dollar. The company is headquartered in Boston, MA, with offices in Atlanta, GA, and Houston, TX.

Media Contacts

Benefits Science Technologies

Mark Hufham mhufham@benefitsscience.com

Share article on social media or email:

The American Academy of Allergy, Asthma & Immunology and National Association of School Nurses Release Guidance on School Attendance, Asthma and COVID-19


AAAAI Logo

“The AAAAI and NASN hope this document can act as a resource to protect school nurses, staff and of course, students while still providing optimal asthma care.” – Robert F. Lemanske Jr., MD, FAAAAI

The American Academy of Allergy, Asthma & Immunology (AAAAI) and National Association of School Nurses (NASN) have released School Attendance, Asthma and COVID-19, a document that contains considerations for school nurses as schools begin to re-open amid the COVID-19 pandemic.

While certain evaluation procedures and treatment recommendations for students with asthma are no longer consistent due to the COVID-19 pandemic and a lack of objective data to guide recommendations, this new document aims to summarize overall recommendations that may be updated as more data surrounding COVID-19 becomes available.

The document addresses considerations when it comes to personal protective equipment (PPE), daily controller medications, and treatment for asthma prior to physical activity. It also touches on asthma action plans and guidance regarding distinguishing symptoms of COVID-19 from asthma. A case scenario is also included to provide school nurses with a concrete example of what procedures should be followed if an asthmatic student reports to them with symptoms of cough or shortness of breath.

Robert F. Lemanske Jr., MD, FAAAAI, a past AAAAI President and Chair of the AAAAI Office of School-based Management of Asthma who helped create the document, expressed why he felt this resource was so important for the AAAAI and NASN to put together. “School nurses are facing a challenging year, particularly for managing conditions such as asthma that may present similar symptoms to COVID-19. While there are no national recommendations, the AAAAI and NASN hope this document can act as a resource to protect school nurses, staff and of course, students while still providing optimal asthma care.”

Donna Mazyck, NASN Executive Director, shared the importance for school nurses to have evidence-based considerations for managing asthma in students with asthma while in school buildings during COVID-19. “Asthma is a common chronic illness in students. A science-based approach to guide school nurse practice improves the health and wellbeing of students with asthma.”

The AAAAI and NASN previously worked together on the AAAAI’s School-based Asthma Management Program (SAMPRO™), which details the elements necessary for the education of children, families, clinicians, and school-based personnel based on a “circle of support” that enhances multidirectional communication and promotes better care for children with asthma within the school setting. Further information on SAMPRO™, which is endorsed by the NASN and others, can be found here.

You can also learn more about asthma and COVID-19 on the American Academy of Allergy, Asthma & Immunology website, aaaai.org.

About AAAAI

The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

About NASN

The National Association of School Nurses is a non-profit specialty nursing organization, first organized in 1968 and incorporated in 1977, representing school nurses exclusively. NASN has more than 17,000 members and 50 affiliates, including the District of Columbia and overseas school nurses. The mission of NASN is to optimize student health and learning by advancing the practice of school nursing. Please visit us at http://www.nasn.org.

###

Share article on social media or email: